Crypto market cap climbs to $2.8T, reaching its highest level in seven months
The total cryptocurrency market cap surged to approximately $2.82 trillion on September 3, marking its highest point since January 2026. After months of grinding lower from the dizzying heights of late 2025, the market appears to have found a second wind.
The rally wasn’t just a Bitcoin story. Major altcoins put up eye-catching numbers, with ZEC, XRP, DOGE, and ADA all posting significant gains.
What’s driving the recovery
In October 2025, total crypto market cap hit an all-time high above $4.27 trillion. What followed was a prolonged slide that chopped roughly a third off that peak.
The approximately 7% climb that pushed the market to this level reflects a genuine shift in sentiment. Bitcoin dominance has hovered in the 57-59% range during the recovery, which is notable. When Bitcoin’s share of the total market stays relatively stable while the whole pie grows, it usually means money is flowing into altcoins alongside the flagship asset rather than rotating out of it.
Altcoin standouts tell the bigger story
ZEC has been the quiet star of 2026. The privacy-focused token posted year-to-date performance exceeding 65% through August, a run that puts most of the crypto top 50 to shame.
XRP, ADA, and DOGE each logged double-digit percentage gains over various timeframes leading into the $2.82 trillion milestone. XRP continues to benefit from its post-litigation positioning as one of the few large-cap tokens with relatively clear regulatory standing in the US.
Context and what comes next
The $2.82 trillion figure is impressive on a relative basis but still sits well below the October 2025 peak. The market would need to climb another roughly 50% to revisit all-time highs.
Bitcoin’s 57-59% dominance is a useful barometer going forward. If dominance starts falling sharply while market cap continues to rise, it could signal the beginning of a more speculative phase where capital chases smaller, riskier tokens. If dominance holds steady or rises, it suggests Bitcoin is leading a more measured advance.
The next level to watch is the $3 trillion mark. Breaking through that round number would put the market back in a range it last inhabited in late 2025.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
3D printing materials supplier Amaero (AMRO.US) restarts US IPO, fundraising drops 60% to $20 million
Amaero (AMRO.US) on Thursday resumed its initial public offering (IPO) plans in the United States and filed new documents with the U.S. Securities and Exchange Commission (SEC), revealing a reduced number of shares to be issued.
Even with Eli Lilly's endorsement, TRex Bio (TRXB.US) struggles to enjoy a premium, as the issue price drops to the lower limit of $14.
Early-stage biotechnology company TRex Bio has priced its IPO at the lower end of the range at $14 per share, raising $116.7 million and achieving a market capitalization of $384 million. The company will be listed on Nasdaq on Friday, with Eli Lilly expressing interest in increasing its stake.
Small molecule biotechnology company Iambic Therapeutics (IAM.US) IPO priced at $15-17 per share, aiming to raise $150 millions.
Iambic Therapeutics plans to raise $150 millions by issuing 9.4 million shares, with an offering price range of $15 to $17 per share.
